Qualcomm: We canceled the purchase deal with Israel's Autotox for $350 million

Qualcomm, the American semiconductor giant, has announced the cancellation of its purchase deal with Israel's Autotox for $350 million. The decision comes after the deal failed to secure approval from regulators despite an extended period of waiting, as reported by Reuters tonight.

The acquisition, initially unveiled in May 2023, faced regulatory scrutiny that prolonged its closure. In August of the same year, the European Commission initiated a regulatory review, followed by an investigation launched by the British Competition Authority in February. The primary concern of regulators revolved around potential competition issues arising from the merger of two significant suppliers of V2X communication chips in Europe, namely Qualcomm and Autotox.

Autotox specializes in V2X technology, facilitating communication between vehicles and various objects in the road environment such as infrastructure and traffic lights. This technology is crucial for advancing safety and efficiency in the automotive sector. Qualcomm, already a major player in the V2X domain, aimed to bolster its position through the acquisition of Autotox.

Reacting to the cancellation, Autotox expressed gratitude towards Qualcomm for its intention to acquire the company while expressing disappointment over the regulatory hurdles. Autotox emphasized its commitment to innovation in the V2X space and highlighted recent advancements in its third-generation chipset, enabling features like automatic braking and advanced V2X applications.

Despite the setback, Autotox remains optimistic about its future prospects, citing partnerships with multiple automotive manufacturers and an electric bicycle company, along with a substantial order backlog. The company affirmed its dedication to product development and customer support while exploring alternative avenues for sustained growth in light of the failed acquisition.

This cancellation marks the second instance of a major acquisition of an Israeli company being called off due to regulatory challenges, following Intel's abandonment of the purchase deal with Tower, an Israeli chip manufacturer, last year.